3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection
NCT01349465
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
249
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C
Interventions
DRUG:
No treatment
Sponsor
Janssen R&D Ireland